Robert E. Stratford

1.7k total citations
59 papers, 1.1k citations indexed

About

Robert E. Stratford is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Robert E. Stratford has authored 59 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 17 papers in Oncology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Robert E. Stratford's work include Drug Transport and Resistance Mechanisms (10 papers), Neuropeptides and Animal Physiology (7 papers) and Advanced Drug Delivery Systems (7 papers). Robert E. Stratford is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Neuropeptides and Animal Physiology (7 papers) and Advanced Drug Delivery Systems (7 papers). Robert E. Stratford collaborates with scholars based in United States, Netherlands and France. Robert E. Stratford's co-authors include Vincent H.L. Lee, William Kielbasa, Ming Hu, Anne H. Dantzig, Yanping Zhu, Tulasi Ponnapakkam, Robert Gensure, Ranjitha Katikaneni, J. Sakon and J. Cory Kalvass and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Cancer Research.

In The Last Decade

Robert E. Stratford

58 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert E. Stratford United States	21	448	294	219	154	153	59	1.1k
Ryoji Konishi Japan	24	606 1.4×	276 0.9×	282 1.3×	178 1.2×	117 0.8×	78	1.4k
Yin Cheong Wong Hong Kong	20	392 0.9×	205 0.7×	150 0.7×	112 0.7×	163 1.1×	41	1.0k
Anita Rudy United States	20	208 0.5×	89 0.3×	109 0.5×	55 0.4×	171 1.1×	31	938
Margaret van Heek United States	21	527 1.2×	306 1.0×	49 0.2×	138 0.9×	123 0.8×	40	2.7k
Ai Tsuji Japan	21	608 1.4×	511 1.7×	50 0.2×	150 1.0×	319 2.1×	74	1.6k
Di Zhao China	27	816 1.8×	183 0.6×	105 0.5×	83 0.5×	227 1.5×	116	1.9k
James Ficorilli United States	17	573 1.3×	270 0.9×	201 0.9×	222 1.4×	129 0.8×	20	1.3k
Ken‐ichi Miyamoto Japan	19	830 1.9×	423 1.4×	40 0.2×	70 0.5×	136 0.9×	83	1.7k
Qing-Yu Zhang United States	25	642 1.4×	345 1.2×	66 0.3×	50 0.3×	77 0.5×	47	1.6k
M. Galli Kienle Italy	23	766 1.7×	189 0.6×	36 0.2×	126 0.8×	125 0.8×	103	1.6k

Countries citing papers authored by Robert E. Stratford

Since Specialization

Citations

This map shows the geographic impact of Robert E. Stratford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Stratford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Stratford more than expected).

Fields of papers citing papers by Robert E. Stratford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Stratford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Stratford. The network helps show where Robert E. Stratford may publish in the future.

Co-authorship network of co-authors of Robert E. Stratford

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Stratford. A scholar is included among the top collaborators of Robert E. Stratford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Stratford. Robert E. Stratford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stratford, Robert E., Wenzhu Mowrey, Na Song, et al.. (2025). 18Fluorine-sodium fluoride positron emission tomography to evaluate arterial calcification in patients with chronic kidney disease: a pilot study. The International Journal of Cardiovascular Imaging. 41(12). 2415–2426.

Ponnapakkam, Tulasi, Muralidharan Anbalagan, Robert E. Stratford, et al.. (2025). Acute toxicological evaluation of bone-targeted parathyroid hormone-related peptide (PTHrP) antagonist to inhibit breast cancer metastases to bone. Toxicology Reports. 15. 102085–102085. 1 indexed citations

Masters, Andrea R., et al.. (2023). Characterization of the Stereoselective Disposition of Bupropion and Its Metabolites in Rat Plasma and Brain. European Journal of Drug Metabolism and Pharmacokinetics. 48(2). 171–187. 1 indexed citations

Mapder, Tarunendu, T. J. Sego, James P. Sluka, et al.. (2022). Multiscale Model of Antiviral Timing, Potency, and Heterogeneity Effects on an Epithelial Tissue Patch Infected by SARS-CoV-2. Viruses. 14(3). 605–605. 13 indexed citations

Stratford, Robert E., et al.. (2021). Oral APX3330 treatment reduces L-CNV lesions in preclinical mouse model and confirms Phase 2 DR/DME clinical dose with sufficient distribution to human retina using PBPK modeling. Investigative Ophthalmology & Visual Science. 62(8). 1073–1073. 4 indexed citations

Masters, Andrea R., et al.. (2020). Population model analysis of chiral inversion and degradation of bupropion enantiomers, and application to enantiomer specific fraction unbound determination in rat plasma and brain. Journal of Pharmaceutical and Biomedical Analysis. 195. 113872–113872. 4 indexed citations

Wright, Thomas D., Margarite D. Matossian, Steven Elliott, et al.. (2019). Pharmacological, Mechanistic, and Pharmacokinetic Assessment of Novel Melatonin-Tamoxifen Drug Conjugates as Breast Cancer Drugs. Molecular Pharmacology. 96(2). 272–296. 32 indexed citations

Bratton, Melyssa R., et al.. (2015). Glyceollin Effects on MRP2 and BCRP in Caco-2 Cells, and Implications for Metabolic and Transport Interactions. Journal of Pharmaceutical Sciences. 105(2). 972–981. 11 indexed citations

Liu, Bin, Carrie H. Croy, Stephen A. Hitchcock, et al.. (2015). Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists. Bioorganic & Medicinal Chemistry Letters. 25(19). 4158–4163. 4 indexed citations

10.

Cole, Richard B., Stephen M. Boué, Melyssa R. Bratton, et al.. (2014). Glyceollin Transport, Metabolism, and Effects on P-Glycoprotein Function in Caco-2 Cells. Journal of Medicinal Food. 17(4). 462–471. 8 indexed citations

11.

Stratford, Robert E., Nieves Vélez de Mendizábal, Thomas I.F.H. Cremers, et al.. (2014). Prediction of brain clozapine and norclozapine concentrations in humans from a scaled pharmacokinetic model for rat brain and plasma pharmacokinetics. Journal of Translational Medicine. 12(1). 203–203. 17 indexed citations

12.

Ponnapakkam, Tulasi, Ranjitha Katikaneni, J. Sakon, Robert E. Stratford, & Robert Gensure. (2013). Treating osteoporosis by targeting parathyroid hormone to bone. Drug Discovery Today. 19(3). 204–208. 62 indexed citations

13.

Cremers, Thomas I.F.H., et al.. (2012). Microdialysis Evaluation of Clozapine and N-Desmethylclozapine Pharmacokinetics in Rat Brain. Drug Metabolism and Disposition. 40(10). 1909–1916. 22 indexed citations

14.

Kielbasa, William, J. Cory Kalvass, & Robert E. Stratford. (2008). Microdialysis Evaluation of Atomoxetine Brain Penetration and Central Nervous System Pharmacokinetics in Rats. Drug Metabolism and Disposition. 37(1). 137–142. 33 indexed citations

15.

Alt, Andrew, Paul L. Ornstein, Scott D. Gleason, et al.. (2007). Anxiolytic-like effects through a GLUK5 kainate receptor mechanism. Neuropharmacology. 52(7). 1482–1487. 19 indexed citations

16.

Li, Cheng, David Fleisher, Lü Li, et al.. (2001). Regional‐Dependent Intestinal Absorption and Meal Composition Effects on Systemic Availability of LY303366, a Lipopeptide Antifungal Agent, in Dogs. Journal of Pharmaceutical Sciences. 90(1). 47–57. 32 indexed citations

17.

Stratford, Robert E., et al.. (1997). Development of a plasma high-performance liquid chromatographic assay for LY303366, a lipopeptide antifungal agent, and its application in a dog pharmacokinetic study. Journal of Chromatography B Biomedical Sciences and Applications. 695(2). 381–387. 14 indexed citations

18.

Hu, Ming, et al.. (1996). Uptake Characteristics of Loracarbef and Cephalexin in the Caco-2 Cell Culture Model: Effects of the Proton Gradient and Possible Presence of a Distinctive Second Component. Journal of Pharmaceutical Sciences. 85(7). 767–772. 7 indexed citations

19.

Nicas, Thalia I., DEBORAH L. MULLEN, J E Flokowitsch, et al.. (1995). Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria. Antimicrobial Agents and Chemotherapy. 39(11). 2585–2587. 45 indexed citations

20.

Lee, Vincent H.L., et al.. (1986). Metabolic and Permeation Barriers to the Ocular Absorption of Topically Applied Enkephalins in Albino Rabbits. Journal of Ocular Pharmacology and Therapeutics. 2(4). 345–352. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact